
Science Sparks @ ACTREC

Publications
- 1. Saha A, Goswami D, Hole A, Bendale K, Chaudhari P, CM Krishna (2025). Serum Raman spectroscopy explorations in Canine cancers: A pilot study. Journal of Raman Spectroscopy.
- 2. Bhat M, Saha P, Narasimhan M, Shelar A, Hole A, CM Krishna, Govekar R (2025). Analysis of lipids by Raman spectroscopy and mass spectrometry provides a detection tool and mechanistic insight into imatinib resistance in CML-BC. Biochimica et Biophysica Acta (BBA) - General Subjects.
- 3. Jadhav PA, Hole A, Saha P, Pansare K, Ghanwat A, Gera P, Bendale K, Krishna CM, Chaudhari P (2025). Exploratory Raman Spectroscopic Studies of Canine Oral Tumour Types. Journal of Biophotonics.
- 4. Ghosh A, Chaubal R, Das C, Parab P, Das S, Maitra A, Majumder PP, Gupta S, Biswas NK (2025). Genomic hallmarks of endocrine therapy resistance in ER/PR+HER2- breast tumours. Communications Biology. 8(1):207.
- 5. Shivshankar S, Patil PS, Deodhar K, Budukh AM (2025). Epidemiology of colorectal cancer: A review with special emphasis on India. Indian Journal of Gastroenterology.
- 6. Keshari R, Bagale R, Rath S, De A, Banerjee R, Sen S, Srivastava R (2025). Transcutaneous delivery of disease-specific PI3K/Akt/mTOR inhibitor-based hybrid nanoparticles in hydrogel system for the management of psoriasis: Insights from in vivo studies. International Journal of Pharmaceutics.

Upcoming Events
22-23 February 2025
ICGC2025 Conference (Choksi Auditorium, TMH): 22-23 Feb 2025 Pre-conference NGS Hands on Workshop at ACTREC Navi Mumbai: 20-21st February 2025 Pre-conference Genetic Counselling (GC) Workshop at TMH, Mumbai: 20-21st February 2025.
March 22, 2025.
At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai.
March 21-23, 2025
At Hotel Crowne Plaza, Rohini, New Delhi
Do You Know?
In 2009, FDA approved Cervarix, a second vaccine that protects against infection by the two HPV types that cause approximately 70% of all cases of cervical cancer worldwide.

Cancer News
Press Information Bureau, 13/02/2025
The Government of India has introduced robust policies, strategic interventions, and financial assistance schemes to enhance prevention, early detection, treatment, and patient care nationwide. This article outlines cancer prevalence, government efforts, financial aid, research...
MedicalXpress, 13/02/2025
Researchers for the first time, established a direct link between aging-related gene expression changes and chromatin accessibility in the mammary gland, which refers to how tightly or loosely DNA is packed within the nucleus. This affects which genes can be turned on or off...
Punepulse, 12/02/2024
A groundbreaking study conducted by researchers from Tata Memorial Centre (TMC), Mumbai, and the National Institute of Biomedical Genomics (NIBMG), Kalyani has uncovered key genomic factors contributing to resistance to hormone (endocrine) therapy...
© 2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)